Treatment for hypertension, male in Syria
Syria: Treatment for hypertension, male was 37.7% in 2019. ▲ Rising
Treatment for hypertension, male in Syria, 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of male adults ages 30-79 with hypertension.
Analysis
In 2019, treatment for hypertension, male in Syria stood at 37.7%. That is the highest value across all 30 years on record.
Compared with earlier readings it is up 1.1% on the previous year and up 20.8% over ten years.
Over the whole period, treatment for hypertension, male in Syria peaked at 37.7% in 2019 and was at its lowest, 16.0%, in 1990.
Syria ranks 81st of 192 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension, male in Syria, year by year
| Year | % of male adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 16.0% | — |
| 1991 | 16.4% | +2.5% |
| 1992 | 16.8% | +2.4% |
| 1993 | 17.3% | +3.0% |
| 1994 | 17.8% | +2.9% |
| 1995 | 18.4% | +3.4% |
| 1996 | 19.0% | +3.3% |
| 1997 | 19.6% | +3.2% |
| 1998 | 20.3% | +3.6% |
| 1999 | 21.1% | +3.9% |
| 2000 | 21.9% | +3.8% |
| 2001 | 22.7% | +3.7% |
| 2002 | 23.7% | +4.4% |
| 2003 | 24.7% | +4.2% |
| 2004 | 25.8% | +4.5% |
| 2005 | 26.9% | +4.3% |
| 2006 | 28.0% | +4.1% |
| 2007 | 29.1% | +3.9% |
| 2008 | 30.2% | +3.8% |
| 2009 | 31.2% | +3.3% |
| 2010 | 32.2% | +3.2% |
| 2011 | 33.1% | +2.8% |
| 2012 | 34.0% | +2.7% |
| 2013 | 34.7% | +2.1% |
| 2014 | 35.4% | +2.0% |
| 2015 | 36.0% | +1.7% |
| 2016 | 36.6% | +1.7% |
| 2017 | 37.0% | +1.1% |
| 2018 | 37.3% | +0.8% |
| 2019 | 37.7% | +1.1% |
Syria compared with similar countries
- Syria's 37.7% is above the median for low income countries, which is 20.3%, 1.9× the median. (25 countries reporting)
- Syria's 37.7% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 37.0%, 1.0× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 18.3% | 16.0% | 21.1% | 10 |
| 2000s | 26.4% | 21.9% | 31.2% | 10 |
| 2010s | 35.4% | 32.2% | 37.7% | 10 |
Countries ranked near Syria
More health data for Syria
- Un projection of annual infant deaths, annual growth rate -2.1 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8632 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,122 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,491 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 7.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 00-04, female, per capita 0.0503 units per person (2025)
- Population ages 00-04, male, annual growth rate 7.65 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2022)
Frequently asked questions
- What is treatment for hypertension, male in Syria?
- Treatment for hypertension, male in Syria was 37.7% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension, male recorded in Syria?
- The highest recorded value was 37.7% in 2019.
- What is the lowest treatment for hypertension, male recorded in Syria?
- The lowest recorded value was 16.0% in 1990.
- How does Syria rank for treatment for hypertension, male?
- Syria ranks 81st out of 192 countries with data for 2019.
- Is treatment for hypertension, male rising or falling in Syria?
- Over the last ten years it is up 20.8%. The long-run trend across the full record is rising.
- Where does this Syria data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.